Cargando…

Potent toxic effects of Taroxaz-104 on the replication of SARS-CoV-2 particles

Polyphenolics and 1,3,4-oxadiazoles are two of the most potent bioactive classes of compounds in medicinal chemistry, since both are known for their diverse pharmacological activities in humans. One of their prominent activities is the antimicrobial/antiviral activities, which are much apparent when...

Descripción completa

Detalles Bibliográficos
Autor principal:	Rabie, Amgad M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier B.V. 2021
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8055500/ https://www.ncbi.nlm.nih.gov/pubmed/33887223 http://dx.doi.org/10.1016/j.cbi.2021.109480

Ejemplares similares

Discovery of Taroxaz-104: The first potent antidote of SARS-CoV-2 VOC-202012/01 strain
por: Rabie, Amgad M.
Publicado: (2021)

Potent Inhibitory Activities of the Adenosine Analogue Cordycepin on SARS-CoV-2 Replication
por: Rabie, Amgad M.
Publicado: (2022)

Cyanorona-20: The first potent anti-SARS-CoV-2 agent
por: Rabie, Amgad M.
Publicado: (2021)

Forodesine and Riboprine Exhibit Strong Anti-SARS-CoV-2 Repurposing Potential: In Silico and In Vitro Studies
por: Rabie, Amgad M., et al.
Publicado: (2022)

Simeprevir Potently Suppresses SARS-CoV-2 Replication and Synergizes with Remdesivir
por: Lo, Ho Sing, et al.
Publicado: (2021)

RETRACTED ARTICLE: Discovery of (E)-N-(4-cyanobenzylidene)-6-fluoro-3-hydroxypyrazine-2-carboxamide (cyanorona-20): the first potent and specific anti-COVID-19 drug
por: Rabie, Amgad M.
Publicado: (2021)

Promising Experimental Anti-SARS-CoV-2 Agent “SLL-0197800”: The Prospective Universal Inhibitory Properties against the Coming Versions of the Coronavirus
por: Rabie, Amgad M., et al.
Publicado: (2023)

Potent Dual Polymerase/Exonuclease Inhibitory Activities of Antioxidant Aminothiadiazoles Against the COVID-19 Omicron Virus: A Promising In Silico/In Vitro Repositioning Research Study
por: Rabie, Amgad M., et al.
Publicado: (2023)

Mitigation of the replication of SARS-CoV-2 by nitric oxide in vitro
por: Akaberi, Dario, et al.
Publicado: (2020)

Targeting ACLY efficiently inhibits SARS-CoV-2 replication
por: Yuen, Terrence Tsz-Tai, et al.
Publicado: (2022)

Novel Investigational Anti-SARS-CoV-2 Agent Ensitrelvir “S-217622”: A Very Promising Potential Universal Broad-Spectrum Antiviral at the Therapeutic Frontline of Coronavirus Species
por: Eltayb, Wafa A., et al.
Publicado: (2023)

Zinc pyrithione is a potent inhibitor of PL(Pro) and cathepsin L enzymes with ex vivo inhibition of SARS-CoV-2 entry and replication
por: Kladnik, Jerneja, et al.
Publicado: (2022)

Punicalagin as an allosteric NSP13 helicase inhibitor potently suppresses SARS-CoV-2 replication in vitro
por: Lu, Lian, et al.
Publicado: (2022)

Human galectin-9 potently enhances SARS-CoV-2 replication and inflammation in airway epithelial cells
por: Du, Li, et al.
Publicado: (2023)

Potent antiviral effect of silver nanoparticles on SARS-CoV-2
por: Jeremiah, Sundararaj S., et al.
Publicado: (2020)

Structural basis for neutralization of SARS-CoV-2 and SARS-CoV by a potent therapeutic antibody
por: Lv, Zhe, et al.
Publicado: (2020)

LY-CoV1404 (bebtelovimab) potently neutralizes SARS-CoV-2 variants
por: Westendorf, Kathryn, et al.
Publicado: (2022)

Antiviral drug screen identifies DNA-damage response inhibitor as potent blocker of SARS-CoV-2 replication
por: Garcia, Gustavo, et al.
Publicado: (2021)

Modulation of type I interferon responses potently inhibits SARS-CoV-2 replication and inflammation in rhesus macaques
por: Hoang, Timothy N., et al.
Publicado: (2022)

Bepridil is potent against SARS-CoV-2 In Vitro
por: Vatansever, Erol C., et al.
Publicado: (2020)

Bepridil is potent against SARS-CoV-2 in vitro
por: Vatansever, Erol C., et al.
Publicado: (2021)

Potent SARS-CoV-2 binding and neutralization through maturation of iconic SARS-CoV-1 antibodies
por: Rouet, Romain, et al.
Publicado: (2021)

Development of potent and effective synthetic SARS-CoV-2 neutralizing nanobodies
por: Stefan, Maxwell A., et al.
Publicado: (2021)

Aprotinin Inhibits SARS-CoV-2 Replication
por: Bojkova, Denisa, et al.
Publicado: (2020)

Inhibition of SARS-CoV replication by siRNA
por: Wu, Chang-Jer, et al.
Publicado: (2005)

Discovery of potent benzoxaborole inhibitors against SARS-CoV-2 main and dengue virus proteases
por: Kühl, Nikos, et al.
Publicado: (2022)

MERS-CoV and SARS-CoV-2 replication can be inhibited by targeting the interaction between the viral spike protein and the nucleocapsid protein
por: Park, Byoung Kwon, et al.
Publicado: (2021)

Highly Neutralizing COVID-19 Convalescent Plasmas Potently Block SARS-CoV-2 Replication and Pneumonia in Syrian Hamsters
por: Takamatsu, Yuki, et al.
Publicado: (2022)

The Metallodrug BOLD-100 Is a Potent Inhibitor of SARS-CoV-2 Replication and Has Broad-Acting Antiviral Activity
por: Labach, Daniel S., et al.
Publicado: (2023)

The role of airborne particles and environmental considerations in the transmission of SARS-CoV-2
por: Shao, Longyi, et al.
Publicado: (2021)

COVID-19 and sexual dysfunction in men: SARS-CoV-2 in the testes
por: Rabie, A.M.
Publicado: (2021)

A dataset comprised of binding interactions for 104,972 antibodies against a SARS-CoV-2 peptide
por: Engelhart, Emily, et al.
Publicado: (2022)

Retraction Note to: Discovery of (E)-N-(4-cyanobenzylidene)-6-fluoro-3-hydroxypyrazine-2-carboxamide (cyanorona-20): the first potent and specific anti-COVID-19 drug
por: Rabie, Amgad M.
Publicado: (2022)

Imatinib is not a potent anti-SARS-CoV-2 drug
por: Zhao, Helong, et al.
Publicado: (2020)

25-Hydroxycholesterol is a potent SARS-CoV-2 inhibitor
por: Zu, Shulong, et al.
Publicado: (2020)

Potent and biostable inhibitors of the main protease of SARS-CoV-2
por: Tsuji, Kohei, et al.
Publicado: (2022)

Emergent SARS-CoV-2 variants: comparative replication dynamics and high sensitivity to thapsigargin
por: Al-Beltagi, Sarah, et al.
Publicado: (2021)

Coronavirus biology and replication: implications for SARS-CoV-2
por: V’kovski, Philip, et al.
Publicado: (2020)

Replication, pathogenicity, and transmission of SARS-CoV-2 in minks
por: Shuai, Lei, et al.
Publicado: (2020)

An all-out assault on SARS-CoV-2 replication
por: Hay, Ronald T.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_pn5d7m5o9qkm0vjsr3oae5shkm